Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease A Ciarmiello, M Cannella, S Lastoria, M Simonelli, L Frati, DC Rubinsztein, ... Journal of Nuclear Medicine 47 (2), 215-222, 2006 | 333 | 2006 |
HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity M Fedele, R Visone, I De Martino, G Troncone, D Palmieri, S Battista, ... Cancer cell 9 (6), 459-471, 2006 | 286 | 2006 |
In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients S Del Vecchio, A Ciarmiello, MI Potena, MV Carriero, C Mainolfi, G Botti, ... European journal of nuclear medicine 24, 150-159, 1997 | 234 | 1997 |
Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer (442 views) A Ciarmiello, S Del Vecchio, P Silvestro, MI Potena, MV Carriero, ... Journal Of Clinical Oncology (ISSN: 0732-183x) 16 (5), 1677-1683, 1998 | 214 | 1998 |
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas M Fedele, F Pentimalli, G Baldassarre, S Battista, AJP Klein-Szanto, ... Oncogene 24 (21), 3427-3435, 2005 | 163 | 2005 |
Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients S Del Vecchio, A Ciarmiello, L Pace, MI Potena, MV Carriero, C Mainolfi, ... Journal of Nuclear Medicine 38 (9), 1348-1351, 1997 | 161 | 1997 |
Unsupervised, automated segmentation of the normal brain using a multispectral relaxometric magnetic resonance approach B Alfano, A Brunetti, EM Covelli, M Quarantelli, MR Panico, A Ciarmiello, ... Magnetic resonance in medicine 37 (1), 84-93, 1997 | 127 | 1997 |
Automated segmentation and measurement of global white matter lesion volume in patients with multiple sclerosis B Alfano, A Brunetti, M Larobina, M Quarantelli, E Tedeschi, A Ciarmiello, ... Journal of Magnetic Resonance Imaging 12 (6), 799-807, 2000 | 118 | 2000 |
Effects of induced asynchrony on left ventricular diastolic function in patients with coronary artery disease S Betocchi, F Piscione, B Villari, L Pace, A Ciarmiello, P Perrone-Filardi, ... Journal of the American College of Cardiology 21 (5), 1124-1131, 1993 | 112 | 1993 |
Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load M Quarantelli, A Ciarmiello, VB Morra, G Orefice, M Larobina, R Lanzillo, ... Neuroimage 18 (2), 360-366, 2003 | 101 | 2003 |
Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease? F Squitieri, L Frati, A Ciarmiello, S Lastoria, O Quarrell Mechanisms of ageing and development 127 (2), 208-212, 2006 | 98 | 2006 |
Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases L Portella, R Vitale, S De Luca, C D’Alterio, C Ierano, M Napolitano, ... PloS one 8 (9), e74548, 2013 | 96 | 2013 |
Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in … F Squitieri, M Cannella, M Simonelli, J Sassone, T Martino, E Venditti, ... CNS neuroscience & therapeutics 15 (1), 1-11, 2009 | 91 | 2009 |
Clinical applications of positron emission tomography (PET) imaging in medicine: oncology, brain diseases and cardiology SL Kitson, V Cuccurullo, A Ciarmiello, D Salvo, L Mansi Current Radiopharmaceuticals 2 (4), 224-253, 2009 | 82 | 2009 |
Early defect of transforming growth factor β1 formation in Huntington’s disease G Battaglia, M Cannella, B Riozzi, S Orobello, ML Maat‐Schieman, ... Journal of cellular and molecular medicine 15 (3), 555-571, 2011 | 80 | 2011 |
18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size A Ciarmiello, G Giovacchini, S Orobello, L Bruselli, F Elifani, F Squitieri European journal of nuclear medicine and molecular imaging 39, 1030-1036, 2012 | 74 | 2012 |
Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins F Squitieri, S Orobello, M Cannella, T Martino, P Romanelli, G Giovacchini, ... European journal of nuclear medicine and molecular imaging 36, 1113-1120, 2009 | 68 | 2009 |
Stereotaxy-based regional brain volumetry applied to segmented MRI: validation and results in deficit and nondeficit schizophrenia M Quarantelli, M Larobina, U Volpe, G Amati, E Tedeschi, A Ciarmiello, ... Neuroimage 17 (1), 373-384, 2002 | 63 | 2002 |
Aripiprazole in the treatment of Huntington’s disease: a case series A Ciammola, J Sassone, C Colciago, NE Mencacci, B Poletti, A Ciarmiello, ... Neuropsychiatric Disease and Treatment, 1-4, 2009 | 60 | 2009 |
Inhibition of early 99mTc-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma S Del Vecchio, A Zannetti, L Aloj, C Caracò, A Ciarmiello, M Salvatore European Journal of Nuclear Medicine and Molecular Imaging 30, 879-887, 2003 | 59 | 2003 |